Pharma Pulse 10/25/24: Improving Site-Sponsor Collaboration, Communication Skills Crucial for Patient Safety & more

From Isolation to Integration: Improving Site-Sponsor Collaboration in Clinical Trial Startup

Clinical research is more complicated and expensive than ever. That means the journey from a medical hypothesis to a widely available treatment requires cooperation from numerous financial, regulatory, and research organizations. The closest working relationships within that ecosystem are between pharmaceutical, biotech, and medical device sponsors, contract research organizations (CROs), and clinical research sites.

Communication Skills Are Crucial for Patient Safety

Pharmacists play a crucial role in health care systems worldwide, where they work alongside other health care professionals to help ensure optimal patient care, medication safety, and improved health outcomes. In today’s complex health care landscape, the pharmacist’s role has evolved significantly beyond simply dispensing medications to a more patient-centered educator position. As such, communication has become an essential skill for today’s pharmacist.

Apple Intelligence Isn’t Very Smart Yet—and Apple’s OK With That

Our columnist reviews the first wave of AI features coming to iPhones with iOS 18.1, and asks Apple’s software chief why so much is still missing.

New Study Reveals Unprecedented Increases in Fentanyl and Stimulant Concentrations in Urine Drug Test Results

A study published in JAMA Network Open, led by Andrew Huhn, PhD, MBA, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, Kelly Dunn, PhD, MBA, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, and co-authored by Millennium Health researchers, illustrates striking increases in the amounts of illicit fentanyl, methamphetamine, and cocaine detected in urine drug testing (UDT) specimens since 2013. The analysis showed that the concentrations of fentanyl and methamphetamine were 8.3 and 5.2 times higher, respectively, in 2023 compared to 2013 (Figure). Cocaine concentrations also doubled across this time period, whereas those for heroin fell by more than half.

Viz.ai on LinkedIn

🙌 We are proud to announce that Viz.ai One™️ is a finalist in the 2024 Pharmaceutical Executive APEX Awards—the only awards show judged entirely by healthcare professionals and the patients they treat.

We are excited that our brand campaign is receiving this recognition and look forward to the winner's announcement on November 13.

#PEAPEXAwards

https://lnkd.in/eHs3P4xk

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs